Skip to main content
Premium Trial:

Request an Annual Quote

Vanderbilt U Med Center Wins $8.6M Stimulus Grant for Genomics Resource

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Vanderbilt University Medical Center will create a new collaborative shared resource intended to accelerate discoveries in genome science and personalized medicine, using an $8.6 million, two-year federal stimulus grant announced today.

The new Vanderbilt Technologies for Advanced Genomics, or VANTAGE, will co-locate and expand four existing core facilities as well as BioVU, the medical center's DNA databank, VUMC said.

The DNA Resources Core and the DNA Sequencing Facility will relocate from Light Hall, while the Functional Genomics Shared Resource Core, formerly the Microarray Shared Resource, will move from Medical Research Building II, the medical center said.

The three core facilities, according to VUMC, will be grouped in the basement of Medical Center North with the Flow Cytometry Core, as well as two facilities to be housed in their first physical home, the Genome Technology Core, and a soon-to-be-installed robotic store for BioVU, which is funded by a separate federal grant.

VANTAGE will operate in 12,500 square feet of laboratory space that will be renovated by early summer 2012, the medical center said.

The grant is the largest awarded to Vanderbilt University by the NIH under the $862 billion American Recovery and Reinvestment Act. According to the university, the NIH has provided $81.6 million in 179 stimulus grants led by more than 160 Vanderbilt scientists.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.